You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

2019 Antiemetic Recommendations for Chemotherapy-Induced Nausea and Vomiting: A Clinical Practice Guideline

ID: GL-C50-09 Jun 2019
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Sarah Salama, Kathy Vu, David Warr, Leta Forbes, Daniela Gallo-Hershberg, Carlo De Angelis, Stephanie Brule, Dayna Comfort, Lisa Randall, Julie Williams

Guideline Objective

The objective of this guideline is to provide clinicians with updated recommendations for prevention and management of chemotherapy-induced nausea and vomiting (CINV) in adult patients, and promote standardized evidence-informed best practices across Ontario.

This update to the 2013 Antiemetic Report is based on current literature, ASCO, NCCN and MASCC/ESMO guidelines, and expert consensus of the Antiemetic Working Group. It includes updates to the recommendations for single-day and multiple-day IV chemotherapy, discussion around cannabinoids, new recommendations for oral chemotherapy and breakthrough CINV, and changes to emetic classification of certain chemotherapy regimens.

Patient Population

Adult patients receiving systemic treatment.

Intended Guideline Users

Clinicians involved in the care of patients receiving systemic treatment (Physicians, Pharmacists, Nurses)

pdf download Summary (PDF) (266.15 KB)
pdf download Full Report (PDF) (413.66 KB)